Evidence map›Paper›PMID 37279171›Full record

ReviewChemical reviews2023

Direct Bottom-Up

Gail A Vinnacombe-Willson, Ylli Conti, Andrei Stefancu, Paul S Weiss, Emiliano Cortés, Leonardo Scarabelli

Abstract readReview
In one paragraph

Review in Chemical reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. High-YieldACS nano · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gail A Vinnacombe-WillsonBioNanoPlasmonics Laboratory, CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, Gipuzkoa 20014, Spain.ORCID 0000-0002-6897-6574
Ylli ContiNANOPTO Group, Institut de Ciència de Materials de Barcelona, Bellaterra, Barcelona 08193, Spain.ORCID 0000-0001-6714-922X
Andrei StefancuNano Institute Munich, Faculty of Physics, Ludwig-Maximilians-University Munich, Königinstraße 10, 80539 Munich, Germany.ORCID 0000-0002-1455-2055
Paul S WeissDepartments of Chemistry and Biochemistry, Bioengineering, and Materials Science and Engineering, University of California, Los Angeles, Los Angeles, California 90095, United States.ORCID 0000-0001-5527-6248
Emiliano CortésNano Institute Munich, Faculty of Physics, Ludwig-Maximilians-University Munich, Königinstraße 10, 80539 Munich, Germany.ORCID 0000-0001-8248-4165
Leonardo ScarabelliNANOPTO Group, Institut de Ciència de Materials de Barcelona, Bellaterra, Barcelona 08193, Spain.ORCID 0000-0002-6830-5893

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmonic gold nanoparticles have been used increasingly in solid-state systems because of their applicability in fabricating novel sensors, heterogeneous catalysts, metamaterials, and thermoplasmonic substrates. While bottom-up colloidal syntheses take advantage of the chemical environment to control size, shape, composition, surface chemistry, and crystallography of the nanostructures precisely, it can be challenging to assemble nanoparticles rationally from suspension onto solid supports or within devices. In this Review, we discuss a powerful recent synthetic methodology, bottom-up

Identifiers

PMID37279171
PMCPMC10347433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.